Fatal gastroparesis in a patient with Parkinson's disease

Movement Disorders

Volumn 23, Issue 1, 2008, Pages 152-153

  Hermanowicz, Neal ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EISENHOWER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; ESOMEPRAZOLE; PANTOPRAZOLE; PRAMIPEXOLE; TRIMETHOBENZAMIDE;

ABDOMINAL DISCOMFORT; AGED; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENDOSCOPY; HUMAN; LETTER; MALE; NAUSEA; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; STOMACH PARESIS; TREATMENT OUTCOME;

AGED; ANTIPARKINSON AGENTS; FATAL OUTCOME; GASTROPARESIS; HUMANS; LEVODOPA; MALE; PARKINSON DISEASE; PNEUMONIA, ASPIRATION; VOMITING;

EID: 39549095133     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21767     Document Type: Letter

References (6)

1. Abbott RD, Ross GW, Petrovitch H, et al. Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord (in press).
2. Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 1997;38 (Suppl 2):2-7.
3. Goetze O, Nikodem AB, Wiezcorek J, et al. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil 2006; 18:369-375.
4. Braak H, Tredici KD, Rub U, de Vos RAI, Jansen Steur ENHJ, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
5. Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, et al. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study. Neurology 2007;5;68:2012-2018.
6. Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998;43:2398-2404.